These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12817776)

  • 1. Osteoporosis panel summary.
    Capron A; Donaldson S; Raisz LG; Swift S
    J Bone Miner Res; 2003 Jun; 18(6):1160-2. PubMed ID: 12817776
    [No Abstract]   [Full Text] [Related]  

  • 2. Placebo controls in clinical trials of new therapies for osteoporosis.
    Levine RJ
    J Bone Miner Res; 2003 Jun; 18(6):1154-9. PubMed ID: 12817775
    [No Abstract]   [Full Text] [Related]  

  • 3. Is it ethical to conduct placebo-controlled clinical trials in the development of new agents for osteoporosis? An industry perspective.
    Rosenblatt M
    J Bone Miner Res; 2003 Jun; 18(6):1142-5. PubMed ID: 12817772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study design in osteoporosis: a European perspective.
    Kanis JA; Alexandre JM; Bone HG; Abadie E; Brasseur D; Chassany O; Durrleman S; Lekkerkerker JF; Caulin F
    J Bone Miner Res; 2003 Jun; 18(6):1133-8. PubMed ID: 12817770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study designs in osteoporosis.
    Temple RJ
    J Bone Miner Res; 2003 Jun; 18(6):1129-32. PubMed ID: 12817769
    [No Abstract]   [Full Text] [Related]  

  • 6. Is the use of placebo controls ethically permissible in clinical trials of agents intended to reduce fractures in osteoporosis?
    Brody BA; Dickey N; Ellenberg SS; Heaney RP; Levine RJ; O'Brien RL; Purtilo RB; Weijer C
    J Bone Miner Res; 2003 Jun; 18(6):1105-9. PubMed ID: 12817764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ethics of placebo-controlled trials.
    Weijer C
    J Bone Miner Res; 2003 Jun; 18(6):1150-3. PubMed ID: 12817774
    [No Abstract]   [Full Text] [Related]  

  • 8. Surrogates for fracture endpoints in clinical trials.
    Khosla S
    J Bone Miner Res; 2003 Jun; 18(6):1146-9. PubMed ID: 12817773
    [No Abstract]   [Full Text] [Related]  

  • 9. When do the federal regulations allow placebo-controlled trials in children?
    Miller FG; Wendler D; Wilfond B
    J Pediatr; 2003 Feb; 142(2):102-7. PubMed ID: 12584527
    [No Abstract]   [Full Text] [Related]  

  • 10. Medicine. Clinical trials and industry.
    Baird P; Downie J; Thompson J
    Science; 2002 Sep; 297(5590):2211. PubMed ID: 12351773
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethics. Clinical trials guidelines at odds with U.S. policy.
    Normile D
    Science; 2008 Oct; 322(5901):516. PubMed ID: 18948510
    [No Abstract]   [Full Text] [Related]  

  • 12. Ethical issues in the design of osteoporosis clinical trials: the state of the question.
    Heaney RP
    J Bone Miner Res; 2003 Jun; 18(6):1117-20. PubMed ID: 12817766
    [No Abstract]   [Full Text] [Related]  

  • 13. Out in the open.
    Nat Biotechnol; 2005 Feb; 23(2):153. PubMed ID: 15696130
    [No Abstract]   [Full Text] [Related]  

  • 14. Trouble at the office.
    Allison M
    Nat Biotechnol; 2008 Sep; 26(9):967-9. PubMed ID: 18779797
    [No Abstract]   [Full Text] [Related]  

  • 15. Recommendations for the clinical evaluation of agents for treatment of osteoporosis: consensus of an expert panel representing the American Society for Bone and Mineral Research (ASBMR), the International Society for Clinical Densitometry (ISCD), and the National Osteoporosis Foundation (NOF).
    Silverman SL; Cummings SR; Watts NB;
    J Bone Miner Res; 2008 Jan; 23(1):159-65. PubMed ID: 17892379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethics and science of placebo-controlled trials.
    Healy D
    J Psychopharmacol; 2008 Aug; 22(6):598-9. PubMed ID: 18308799
    [No Abstract]   [Full Text] [Related]  

  • 17. Clarifying standards for using placebos.
    Levine RJ; Carpenter WT; Appelbaum PS
    Science; 2003 Jun; 300(5626):1659-61. PubMed ID: 12805520
    [No Abstract]   [Full Text] [Related]  

  • 18. Summary--curing osteoporosis.
    Cummings S
    J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):409. PubMed ID: 15758284
    [No Abstract]   [Full Text] [Related]  

  • 19. Is it ethical to use placebos in osteoporosis trials?
    Ragi-Eis S; Zerbini CA; Provenza JR; Griz LH; de Gregório LH; Russo LA; Silva NA; Borges JL; de Souza AC; Castro ML; Lewiecki EM
    J Clin Densitom; 2006; 9(3):274-80. PubMed ID: 16931344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cautious welcome for FDA pharmacogenomics guidance.
    Katsnelson A;
    Nat Biotechnol; 2005 May; 23(5):510. PubMed ID: 15877053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.